Bringing Cures To
MENAT Patients

About Us
We are a leading pharmaceutical company engaging the relevant stakeholders to provide fast track access for rare disease and specialty drugs for the MENAT Region.
Our History
Established more than a decade ago, we are the commercial partner of choice for innovative biotech and pharmaceutical companies entering the MENAT Region.
Message From Our Founders
Our founders saw significant gaps in meeting the needs of people living with rare diseases in the MENAT Region and decided to take on these challenges.

Latest News

news
30 January 2024
Abdul Latif Jameel Health announces a strategic acquisition of a ma...
Dubai, UAE; January 30, 2024: Abdul Latif Jameel Health, part of Abdul Latif Jameel, a nearly 80-year old intern...
news
01 March 2023
Genpharm and Apellis Pharmaceuticals Enter in an Exclusive Agreement
Dubai, March 1st 2023   Genpharm is pleased to announce it has entered into an exclusive agreement with Apellis Pharmaceuticals...
news
20 January 2022
argenx and Genpharm Sign Exclusive Commercial and Distribution Agre...
Genpharm Gains Exclusive Rights to Commercialize Vyvgart ™ (efgartigimod alfa-fcab) in Generalized Myasthenia Gravis in the Middle E...
news
11 January 2022
Amicus Therapeutics and Genpharm Services Sign Distribution Agreeme...
Amicus Therapeutics and Genpharm Services Sign Distribution Agreement for Galafold for the Treatment of Amenable Patients Living wit...
news
20 January 2021
Genpharm Enters into Agreement with Orchard Therapeutics
Genpharm is proud to announce that it has entered into an agreement with Orchard Therapeutics for the commercializati...
news
15 October 2020
Genpharm features in Rare Revolution Magazine
We are very pleased to have participated in Rare Revolution Magazine Autumn 2020 Issue. Not only is the edition full of insightful a...
news
30 July 2020
Genpharm is proud to announce the appointment of Mr. Mark Rothera t...
Genpharm is proud to announce the appointment of Mr. Mark Rothera to the company’s executive board. Mark joins the board, ...
news
10 June 2020
Genpharm enters into Commercial Agreement with Ultragenyx for the M...
Genpharm is proud to announce that it has entered into an agreement with Ultragenyx for the commercialization and dis...
news
30 April 2020
Shedding lights and raising awareness on Rare Disease in the Middle...
Shedding lights and raising awareness on Rare Disease in the Middle East: Genpharm’s primary mission and managements’ go...
news
27 April 2020
Genpharm signs with Biohaven Pharmaceuticals
Genpharm signs with Biohaven Pharmaceuticals for distribution of Nurtec ODT in the Middle East, an innovative, effective and safe or...

Genpharm in Numbers

0
Territories
Covered
0
Rare Disease and Specialty Products
In A Growing Portfolio
0
And A Growing Number of Rare Disease
Patients Treated

Capabilities and Expertise

Market Access
We ensure that eligible patients can access innovative and effective drugs quickly and consistently.
Education and Diagnostic Support
We support Healthcare Providers in early diagnosis and disease management of patients.
Disease Awareness 
We disseminate updated scientific and medical information on disease symptoms and management, as well as ma...

Geographical Reach

UAE
KSA
Kuwait
Turkey
Lebanon
KSA Scientific Office
Abdullah Sulaiman Al Hamdan Street
P.O. Box 911 Riyadh 11421
Riyadh
KSA
Google Maps
Turkey Liaison Office
Oran Mahallesi, Kudus Caddesi
No:6/1 İç Kapı No:1
Cankaya Ankara Turkiye
Google Maps
UAE Head Office
Business Bay
Al Manara Tower
Office 2805
Dubai
Google Maps
Lebanon Office
Qubic Business Center
7th Floor
Office C
Beirut
Google Maps
Kuwait Office
Block 7, St 67 - Parcel 15
Building 13
Floor 10 - Flat 10
Salmiya
Google Maps

Our Partners